ClinicalTrials.gg
CompletedNCT07892781Updated Oct 23, 2026

Effect of a 12-Week Aerobic Exercise Program on Cardiac, Respiratory, Metabolic Health and Functional Fitness in Healthy Young Adults

An interventional study of Structured Multicomponent exercise intervention program in Exercise Activity, sponsored by Shaheed Zulfiqar Ali Bhutto Medical University. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Shaheed Zulfiqar Ali Bhutto Medical University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Aug 2025, registered Oct 2026).
Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

This randomized controlled trial evaluated the effects of a structured 12-week multicomponent exercise program with an aerobic emphasis on cardiovascular, respiratory, metabolic, and functional fitness outcomes in healthy sedentary young adults aged 18-30 years. Seventy participants were randomly allocated in a 1:1 ratio to an exercise group or a control group. The exercise group participated in supervised exercise sessions three times per week for 12 weeks, while the control group continued their usual lifestyle. Outcomes were assessed at baseline and after 12 weeks and included resting heart rate, blood pressure, body mass index, basal metabolic rate, pulmonary function, six-minute walk distance, Cooper 12-minute run performance, agility, and flexibility.

02

Conditions studied

  • Exercise Activity

Keywords

  • Aerobic Exercise
  • Cardiovascular Fitness
  • Pulmonary Function
  • Functional Fitness
  • Healthy Young Adults
03

In context

Lead sponsor

Shaheed Zulfiqar Ali Bhutto Medical University is the lead sponsor of 36 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:age 18 to 25 years, sedentary lifestyle, healthy young adults -

Exclusion Criteria:CVS, RESPIRATORY OR METABOLIC DISORDERS, pregnancy, any conditions limiting participation in exercise

-

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • No intervention
    Control Group

    Participants continued their normal lifestyle and were not included in a structured 12 week aerobic exercise intervention

  • Experimental
    Exercise Group

    Participants were involved in a structured 12 weeks multi component Exercise Program with aerobic emphasis consisting of 45 min sessions 3 times a week .

    Other: Structured Multicomponent exercise intervention program

Interventions

  • OtherStructured Multicomponent exercise intervention program

    A Structured 12 week multicomponent exercise intervention program with aerobic emphasis consisting of 3 sessions of 45 min per week.

06

What researchers measure

Primary outcomes

  1. RESTING HEART RATE

    resting heart rate in bpm was measured at baseline weekn0 and at week 12

    Time frame: Baseline week 0 and week12

Secondary outcomes

  1. Blood pressure

    Changes in Bp

    Time frame: Week 0 and 12

  2. FEV1

    Changes in fev1

    Time frame: Week 0 and 12

  3. Agility test

    Changes in agility

    Time frame: Week 0 and 12

  4. BMI

    Changed in BMI

    Time frame: Week 0 and 12

  5. Cooper Test

    Changes in Cooper test

    Time frame: Week 0 and 12

  6. BMR

    Changes in BMR

    Time frame: Week 0 and 12

  7. FVC

    Changed in FVC

    Time frame: Week 0 and 12

  8. Sit and reach test

    Changes in sit and reach test

    Time frame: Week 0 and 12

  9. Six minute walk test

    Changes in six min walk test

    Time frame: Week 0 and 12

07

Study locations

1 site
  • Federal Medical College Islamabad
    Islamabad, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2025 to primary completion in Nov 2025, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 18, 2026
First posted
Oct 23, 2026
StartActual
Aug 4, 2025
Primary completionActual
Nov 5, 2025
CompletionActual
Nov 5, 2025
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07892781
Lead sponsor
Shaheed Zulfiqar Ali Bhutto Medical University
Responsible party
Dr Maryam Iqbal (MPhil Scholar, Department of Physiology, Federal Medical College, Shaheed Zulfiqar Ali Bhutto Medical University) — Principal investigator
First posted
Oct 23, 2026
Start date
Aug 4, 2025
Primary completion
Nov 5, 2025
Completion
Nov 5, 2025
Last update
Oct 23, 2026

Study contacts

Prof Dr Shemaila Saleem, PhD physiology
study chair · Shaheed Zulfiqar Ali Bhutto Medical University Islamabad

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion